In the field of bio-tech, it can take 10 years and millions of dollars to see if an experimental idea might turn into a life-saving treatment—if it ever does. Noubar Afeyan fully understood those risks when he co-founded Moderna in 2010. He and his col...

Moderna and Flagship Pioneering: Noubar Afeyan

By NPR Oct 11, 2021 | 12:10 AM
Full Page Ad